LACK OF CATECHOLAMINE INVOLVEMENT IN THE INCREASED LUTEINIZING-HORMONE RELEASE DUE TO BLOCKADE OF KAPPA-OPIOID RECEPTORS IN THE MEDIAL BASAL HYPOTHALAMUS DURING MIDPREGNANCY IN THE RAT
Sj. Zhen et Rv. Gallo, LACK OF CATECHOLAMINE INVOLVEMENT IN THE INCREASED LUTEINIZING-HORMONE RELEASE DUE TO BLOCKADE OF KAPPA-OPIOID RECEPTORS IN THE MEDIAL BASAL HYPOTHALAMUS DURING MIDPREGNANCY IN THE RAT, Brain research, 642(1-2), 1994, pp. 178-184
Blockade of kappa-opioid receptors in the medial basal hypothalamus (M
BH) with nor-binaltorphimine (nor-BNI) stimulates luteinizing hormone
(LH) release during midpregnancy in the rat [48]. The objective of thi
s study was to determine whether norepinephrine (NE) or dopamine (DA)
mediates the LH response to blockade of MBH kappa-opioid receptors on
days 13-17 of pregnancy in the rat. Two experiments were conducted. In
the first, push-pull perfusion in conjunction with HPLC was used to m
onitor in vivo NE release in the MBH occurring in response to (a) arti
ficial CSF followed by CSF containing nor-BNI (40 mu g/h), (b) desipra
mine (DMI, a NE reuptake blocker, 10 mu M) in CSF followed by DMI, and
(c) DMI followed by DMI + nor-BNI. Blood samples were taken at 12 min
intervals concurrent with push-pull perfusate samples. Plasma LH leve
ls were determined by RIA. Nor-BNI significantly increased LH release
compared to CSF alone, but perfusate NE was undetectable in either per
fusion period. However, perfusion with CSF containing 100 mM K+ in the
se rats markedly increased perfusate NE levels, indicating noradrenerg
ic nerve terminals were present at the perfusion sites in the MBH. Add
ition of DMI to the CSF significantly increased perfusate NE levels, b
ut produced no change in LH release. Nor-BNI + DMI perfusion increased
LH secretion similar to nor-BNI alone, but produced no additional inc
rease in MBH perfusate NE levels compared to perfusion with DMI alone.
In the second experiment, push-pull perfusion in the MBH with nor-BNI
was done in rats pretreated either with the NE synthesis inhibitor FL
A-63 (25 mg/kg, s.c.), the alpha-adrenergic receptor blocker phentolam
ine (5 mg/kg, i.v.), the DA receptor antagonist d-butaclamol (1 mg/kg,
s.c.), or vehicle. None of these drug treatments affected the increas
ed LH release occurring during MBH perfusion with nor-BNI. The present
results demonstrate that neither NE nor DA mediates the increased LH
release occurring in response to blockade of kappa-opioid receptors in
the MBH during midpregnancy in the rat.